Toxins News and Research

RSS

Review outlines effective approaches to reduce recurrent hepatic encephalopathy

Hepatic encephalopathy (HE) is a neurologic complication of advanced liver disease, causing impaired functioning, reduced quality of life (QOL), and increased hospitalisation and mortality.

31 Jul 2026

Mouse study links leaky gut to severe food allergies

A "leaky gut" might increase the severity of food allergies, according to new research conducted in mice and published in The Journal of Immunology.

31 Jul 2026

New ultrasound technique breaches blood brain barrier to treat gliomas

In a promising sign for the potential of focused sound waves to improve care for brain tumors, UVA Health researchers have determined that tumors called gliomas may be even more receptive to targeted drug delivery than normal brain tissue.

30 Jul 2026

Research offers a promising way to develop potent antivenoms against deadly snakebites

University of Maryland researchers discovered a new approach to treating venomous snake bites-using the same toxin-blocking proteins that snakes evolved to protect themselves.

29 Jul 2026

Researchers examine mosquitoes’ resistance mechanisms to common insecticide

Traditionally, public health programs have relied on chemicals for mosquito management, and this may be why combating them is becoming more difficult.

29 Jul 2026

Novel interventional approach successfully treats rare hepatic myelopathy

Hepatic myelopathy (HM) is a rare neurological complication of decompensated chronic liver disease that profoundly impairs quality of life.

28 Jul 2026

UVA researchers develop a new experimental approach to target glioblastoma

University of Virginia Comprehensive Cancer Center scientists have developed a promising new experimental approach to targeting glioblastoma, the most common and deadliest brain cancer.

22 Jul 2026

Study explores membrane repair mechanisms in leishmaniasis parasites

Texas Tech University faculty Peter Keyel and Kai Zhang are teaming up to build foundational knowledge concerning leishmaniasis, a common, but neglected protozoan parasitic disease.

20 Jul 2026

New drug candidate treats severe fatty liver disease by improving gut health

Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving gut health, according to a study published in The Journal of Clinical Investigation.

7 Jul 2026

Phenolic compounds linked to precocious puberty or early breast development in girls

Research from the University of Granada, recently published in the European Journal of Pediatrics, has revealed that girls with higher levels of bisphenol A (a component of plastics and epoxy-phenolic resins) and benzophenones (ultraviolet filters) in their urine are more likely to experience precocious puberty or early breast development.

7 Jul 2026

Sustainable oyster meat extract may reduce human intestinal inflammation

Ongoing research provides evidence that readily-available and sustainable oyster meat extract may have powerful anti-inflammatory effects on human intestinal cells.

7 Jul 2026

Natural microbial compound helps protect the gut from chronic inflammation

University of Louisville researchers have discovered how a naturally occurring microbial compound may help protect the gut and support future treatment strategies for inflammatory bowel disease (IBD).

24 Jun 2026

Longer breastfeeding links to fewer ADHD symptoms in children

Longer durations of full breastfeeding are linked to fewer ADHD symptoms in children, suggesting early feeding patterns may influence neurodevelopment.

23 Jun 2026

WashU study identifies shared target for a new diarrhea vaccine

The bacteria enterotoxigenic E. coli and Shigella together cause hundreds of millions of infections each year and are among the leading causes of diarrheal death, especially in children.

17 Jun 2026

Researchers eliminate embryonic senescent cells, triggering severe neurovascular flaws

Among the body's most crucial protective features are the brain barrier systems, including the blood-brain and blood-cerebrospinal fluid (CSF) barriers. These barriers are made of highly specialized cells that allow essential nutrients to enter, yet repel dangerous toxins and pathogens that may be circulating in the bloodstream. Scientists have long known what these barriers do, but less about how they are built during development.

17 Jun 2026

Cellular process discovery may lead to new cancer treatments

A molecular geneticist at Montana State University has discovered a cellular process once believed impossible by scientists – the creation of the amino acid cysteine within a living cell when the cell's primary systems to do so fail. The discovery may one day lead to new cancer treatments.

12 Jun 2026

Researchers discover 45 new toxins produced by Salmonella bacteria

Researchers at the University of São Paulo (USP) in Brazil have discovered 45 new toxins produced by Salmonella bacteria, some of which are associated with foodborne infections.

11 Jun 2026

WHO's new estimates of foodborne diseases may improve global prevention

Researchers from DTU have contributed to the international scientific work behind the WHO's new estimates of the global burden of foodborne diseases, providing countries with a stronger evidence base for preventing illness and prioritising action.

8 Jun 2026

EU-funded project launches digital campaign to explain climate-driven food safety threats

To mark World Food Safety Day on 7 June, the EU-funded HOLiFOOD project is launching a digital campaign with six European influencers to help consumers better understand how climate change may affect food safety, and how science can support earlier detection and prevention of emerging risks.

4 Jun 2026

Genetically-modified hookworms successfully deliver medicine to animal hosts

Hookworms, intestinal parasites that infect hundreds of millions of people in under-resourced tropical regions around the globe, have evolved to survive inside the human gut for years, secreting molecules that enable co-existence with their hosts.

3 Jun 2026